Dihydrotanshinone I Specifically Inhibits NLRP3 Inflammasome Activation and Protects Against Septic Shock In Vivo
The abnormal activation of the NLRP3 inflammasome is closely related to the occurrence and development of many inflammatory diseases. Targeting the NLRP3 inflammasome has been considered an efficient therapy to treat infections. We found that dihydrotanshinone I (DHT) specifically blocked the canoni...
Saved in:
Main Authors: | Ziying Wei (Author), Xiaoyan Zhan (Author), Kaixin Ding (Author), Guang Xu (Author), Wei Shi (Author), Lutong Ren (Author), Zhie Fang (Author), Tingting Liu (Author), Xiaorong Hou (Author), Jia Zhao (Author), Hui Li (Author), Jiayi Li (Author), Zhiyong Li (Author), Qiang Li (Author), Li Lin (Author), Yan Yang (Author), Xiaohe Xiao (Author), Zhaofang Bai (Author), Junling Cao (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2021-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Germacrone Attenuates Hepatic Stellate Cells Activation and Liver Fibrosis via Regulating Multiple Signaling Pathways
by: Zhiyong Li, et al.
Published: (2021) -
Corrigendum: The Combination of Schisandrol B and Wedelolactone Synergistically Reverses Hepatic Fibrosis via Modulating Multiple Signaling Pathways in Mice
by: Yongqiang Ai, et al.
Published: (2021) -
The Combination of Schisandrol B and Wedelolactone Synergistically Reverses Hepatic Fibrosis Via Modulating Multiple Signaling Pathways in Mice
by: Yongqiang Ai, et al.
Published: (2021) -
Schisandrin C enhances type I IFN response activation to reduce tumor growth and sensitize chemotherapy through antitumor immunity
by: Huijie Yang, et al.
Published: (2024) -
Tanshinone I specifically suppresses NLRP3 inflammasome activation by disrupting the association of NLRP3 and ASC
by: Jia Zhao, et al.
Published: (2023)